Innate immune responses to transplants: A significant variable with cadaver donors

Immunity

Volumn 14, Issue 4, 2001, Pages 369-376

  Baldwin III, William M ^a   Larsen, Christian P ^b   Fairchild, Robert L ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b EMORY UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ALLOIMMUNITY; CADAVER DONOR; CELL ADHESION; CHEMOTAXIS; CYTOKINE RELEASE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNE RESPONSE; INFLAMMATORY CELL; ISCHEMIA; LYMPHOCYTIC INFILTRATION; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION; REVIEW;

EID: 0035041301     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00117-0     Document Type: Review

References (63)

1. Arnaout M.A., Spits H., Terhorst C., Pitt J., Todd R.F. III. Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency. Effects of cell activation on Mo1/LFA-1 surface expression in normal and deficient leukocytes. J. Clin. Invest. 74:1984;1291-1300.
2. Ayalon O., Hughes E.A., Cresswell P., Lee J., O'Donnell L., Pardi R., Bender J.R. Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis. Proc. Natl. Acad. Sci. USA. 95:1998;2435-2440.
3. Bajtay Z., Jozsi M., Banki Z., Thiel S., Thielens N., Erdei A. Mannan-binding lectin and C1q bind to distinct structures and exert differential effects on macrophages. Eur. J. Immunol. 30:2000;1706-1713.
4. Baldwin W.M. III, Samaniego-Picota M., Kasper E.K., Clark A., Czader M., Rohde C., Zachary A.A., Sanfilippo F., Hruban H. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation. 68:1999;894-900.
5. Benzaquen L.R., Nicholson-Weller A., Halperin J.A. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J. Exp. Med. 179:1994;985-992.
6. Bingaman A.W., Ha J., Waitze S.Y., Durham M., Cho H.R., Tucker-Burden C., Hendrix R., Cowan S.R., Pearson T.C., Larsen C.P. Vigorous allograft rejection in the absence of danger. J. Immunol. 164:2000;3065-3071.
7. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense. function and regulation by innate cytokines Annu. Rev. Immunol. 17:1999;189-220.
8. Blakely M.L., Vanderwerf W.J., Berndt M.C., Dalmasso A.P., Bach F.H., Hancock W.W. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation. 58:1994;1059-1066.
9. Blancho G., Buzelin F., Dantal J., Hourmant M., Cantarovich D., Baatard R., Bonneville M., Vie H., Bugeon L., Soulillou J.P. Evidence that early acute renal failure may be mediated by CD3- CD16+ cells in a kidney graft recipient with large granular lymphocyte proliferation. Transplantation. 53:1992;1242-1247.
10. Brooimans R.A., Stegmann A.P., van Dorp W.T., van der Ark A.A., van der Woude F.J., van Es L., Daha M.R. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J. Clin. Invest. 88:1991;379-384.
11. Celi A., Pellegrini G., Lorenzet R., De Blasi A., Ready N., Furie B.C., Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc. Natl. Acad. Sci. USA. 91:1994;8767-8771.
12. Chandraker A., Takada M., Nadeau K.C., Peach R., Tilney N.L., Sayegh M.H. CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int. 52:1997;1678-1684.
13. Collard C.D., Vakeva A., Morrissey M.A., Agah A., Rollins S.A., Reenstra W.R., Buras J.A., Meri S., Stahl G.L. Complement activation after oxidative stress. role of the lectin complement pathway Am. J. Pathol. 156:2000;1549-1556.
14. Collinge M., Pardi R., Bender J.R. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion. J. Immunol. 161:1998;1589-1593.
15. D'Alessandro A.M., Pirsch J.D., Knechtle S.J., Odorico J.S., Van der Werf W.J., Collins B.H., Becker Y.T., Kalayoglu M., Armbrust M.J., Sollinger H.W. Living unrelated renal donation. the University of Wisconsin experience Surgery. 124:1998;604-610.
16. DiScipio R.G., Daffern P.J., Jagels M.A., Broide D.H., Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J. Immunol. 162:1999;1127-1136.
17. Du Clos T.W. Function of C-reactive protein. Ann. Med. 32:2000;274-278.
18. Ember J.A., Sanderson S.D., Hugli T.E., Morgan E.L. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am. J. Pathol. 144:1994;393-403.
19. Fitch J.C., Rollins S., Matis L., Alford B., Aranki S., Collard C.D., Dewar M., Elefteriades J., Hines R., Kopf G.et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation. 100:1999;2499-2506.
20. Foreman K.E., Vaporciyan A.A., Bonish B.K., Jones M.L., Johnson K.J., Glovsky M.M., Eddy S.M., Ward P.A. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1994;1147-1155.
21. Gorulay W.A., Chambers W.H., Monaco A.P., Maki T. Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation. 65:1998;727-734.
22. Griselli M., Herbert J., Hutchinson W.L., Taylor K.M., Sohail M., Krausz T., Pepys M.B. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J. Exp. Med. 190:1999;1733-1740.
23. Halloran P.F., Autenried P., Ramassar V., Urmson J., Cockfield S. Local T cell responses induce widespread MHC expression. Evidence that INFg induces its own expression in remote sites J. Immunol. 148:1992;3837-3846.
24. Harris K.R., Digard N.J., Lee H.A. Serum C-reactive protein. A useful and economical marker of immune activation in renal transplantation. Transplantation. 61:1996;1593-1600.
25. Hattori R., Hamilton K.K., McEver R.P., Sims P.J. Complement proteins C5b-C9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J. Biol. Chem. 264:1989;9053-9060.
26. Heidecke C.M., Araujo J.-L., Kupiec-Weglinski J.W., Abbud-Filho M., Araneda D., Stadler J., Siewert J., Strom T.B., Tilney N.L. Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts. Transplantation. 40:1985;441-444.
27. Kilgore K.S., Flory C.M., Miller B.F., Evans V.M., Warren J.S. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am. J. Pathol. 149:1996;953-961.
28. Kondo T., Morita D., Watarai Y., Auerbach M.B., Taub D.D., Novick A.C., Toma H., Fairchild R.L. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation. 69:2000;969-977.
29. Kummer J.A., Wever P.C., Kamp A.M., ten Berge I.J.M., Hack C.E., Weenig J.J. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Int. 47:1995;70-77.
30. Lachmann P.J. The control of homologous lysis. Immunol. Today. 12:1991;312-315.
31. Lanier L.L. Follow the leader. NK cell receptors for classical and nonclassical MHC class I Cell. 92:1998;705-707.
32. Ljunggren H.G., Karre K. In search of the "missing self" MHC molecules and NK cell recognition Immunol. Today. 11:1990;237-244.
33. Lovik G., Vaage J.T., Dissen E., Szpierer C., Ryan J.C., Bolstad B. Characterization and molecular cloning of rat C1qRp, a receptor on NK cells. Eur. J. Immunol. 30:2000;3355-3362.
34. Manilay J.O., Sykes M. Natural killer cells and their role in graft rejection. Curr. Opin. Immunol. 10:1998;532-538.
35. Markus P.M., van den Brink M., Cai X., Harnaha J., Palomba L., Hiserodt J.C., Cramer D.V. Effect of selective depletion of natural killer cells on allograft rejection. Transplant. Proc. 23:1991;178-179.
36. McDouall R.M., Batten P., McCormack A., Yacoub M.H., Rose M.L. MHC class II expression on human heart microvascular endothelial cells. exquisite sensitivity to interferon-gamma and natural killer cells Transplantation. 64:1997;1175-1180.
37. Moretta A., Biassoni R., Bottino C., Mingari M.C., Moretta L. Human NK-cell receptors. Immunol. Today. 21:2000;228-234.
38. Multhoff G., Mizzen L., Winchester C.C., Milner C.M., Wenk S., Eissner G., Kampinga H.H., Laumbacher B., Johnson J. Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Exp. Hematol. 27:1999;1627-1636.
39. Nataf S., Davoust N., Ames R.S., Barnum S.R. Human T cells express the C5a receptor and are chemoattracted to C5a. J. Immunol. 162:1999;4018-4023.
40. Nemlander A., Saksela E., Häyry P. Are "natural killer" cells involved in allograft rejection? Eur. J. Immunol. 13:1983;348-350.
41. Parker S.J., Sadlon T.A., Gordon D.L. Enhancement of NK cell-mediated antibody-dependent lysis of recombinant gp120-coated CD4 cells by complement. J. Infect. Dis. 171:1995;186-189.
42. Petersson E., Ostraat O., Ekber H., Hansson J., Simanaitis M., Brodin T., Dohlsten M., Hedlund G. Allogeneic heart transplantation activates alloreactive NK cells. Cell. Immunol. 175:1997;25-32.
43. Pratt J.R., Abe K., Miyazaki M., Zhou W., Sacks S.H. In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am. J. Pathol. 157:2000;825-831.
44. Qian Z., Wasowska B.A., Behrens E., Brody J.R., Kadkol S.S., Cangello D.L., Horwitz L., Liu J., Lowenstein C., Hess A.D.et al. C6 produced by macrophages contributes to cardiac allograft rejection. Am. J. Pathol. 155:1999;1293-1302.
45. Rovere P., Peri G., Fazzini F., Bottazzi B., Doni A., Bondanza A., Zimmermann V.S., Garlanda C., Fascio U., Sabbadini M.G.et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood. 96:2000;4300-4306.
46. Shaw P.X., Horkko S., Chang M.K., Curtiss L.K., Palinski W., Silverman G.J., Witztum J.L. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105:2000;1731-1740.
47. Sims P.J., Wiedmer T. The response of human platelets to activated components of the complement system. Immunol. Today. 12:1991;338-342.
48. Szalai A.J., van Ginkel F.W., Wang Y., McGhee J.R., Volanakis J.E. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component. J. Immunol. 165:2000;1030-1035.
49. Takada M., Nadeau K.C., Shaw G.D., Marquette K.A., Tilney N.L. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J. Clin. Invest. 99:1997;2682-2690.
50. Taub D.D., Sayers T.J., Carter C.R., Ortaldo J.R. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:1995;3877-3888.
51. Tedesco F., Pausa M., Nardon E., Introna M., Mantovani A., Dobrina A. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J. Exp. Med. 185:1997;1619-1627.
52. Timonen T. Natural killer cells. endothelial interactions, migration, and target cell recognition J. Leukoc. Biol. 62:1997;693-701.
53. Timonen T., Patarroyo M., Gahmber C.G. J. Immunol. 141:1988;1041-1046.
54. Tsuji R.F., Kawikova I., Ramabhadran R., Akahira-Azuma M., Taub D., Hugli T.E., Gerard C., Askenase P.W. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 165:2000;1588-1598.
55. Van Loo A.A., Vanholder R.C., Bernaert P.R., Vermassen F.E., Van der Vennet M., Lameire N.H. Pretransplantation hemodialysis strategy influences early renal graft function. J. Am. Soc. Nephrol. 9:1998;473-481.
56. Watson C.A., Pezelbauer P., Zhou J., Pardi R., Bender J.R. Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and -independent mechanisms. J. Immunol. 154:1995;3222-3233.
57. Weiser M.R., Williams J.P., Moore F.D. Jr., Kobzik L., Ma M., Hechtman H.B., Carroll M.C. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183:1996;2343-2348.
58. Weisman H.F., Bartow T., Leppo M.K., Marsh H.C. Jr., Carson G.R., Concino M.F., Boyle M.P., Roux K.H., Weisfeldt M.L., Fearon D.T. Soluble human complement receptor type 1. In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis Science. 249:1990;146-151.
59. Weyrich A.S., Elstad M.R., McEver R.P., McIntyre T.M., Moore K.L., Morrissey J.H., Prescott S.M., Zimmerman G.A. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 97:1996;1525-1534.
60. Wilhelm M.J., Pratschke J., Beato F., Taal M., Kusaka M., Hancock W.W., Tilney N.L. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation. 102:2000;2426-2433.
61. Wolbink G.J., Brouwer M.C., Buysmann S., ten Berge I.J., Hack C.E. CRP-mediated activation of complement in vivo. assessment by measuring circulating complement-C-reactive protein complexes J. Immunol. 157:1996;473-479.
62. Yoneda O., Imai T., Goda S., Inoue H., Yamauchi A., Okazaki T., Imai H., Yoshie O., Bloom E.T., Domae N., Umehara H. Fractalkine-mediated endothelial cell injury by NK cells. J. Immunol. 164:2000;4055-4062.
63. Zhu W., Roma P., Pellegatta F., Catapano A.L. Oxidized-LDL induce the expression of heat shock protein 70 in human endothelial cells. Biochem. Biophys. Res. Comm. 200:1994;389-394.